3218 PACEBOM in relapsed/refractory (R/R) lymphoma in the rituximab (R) era. (September 2015) - Tamjid, B.; McKendrick, J.; Doig, R.; Hosking, P.; James, P.; Anthony, S.; Hawkes, E.